| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189019 Antistasin derived anticoagulant protein |
| 02/23/1993 | CA1313867C Pentasaccharides |
| 02/21/1993 | CA2073138A1 Use of 9,12,15-octadecatriene-6-ynoic acid |
| 02/20/1993 | CA2076311A1 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/18/1993 | WO1993000095A3 Bicyclic fibrinogen antagonists |
| 02/17/1993 | CN1069025A Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/16/1993 | US5187157 Peptide boronic acid inhibitors of trypsin-like proteases |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | CA1313618C Lyophilization of red blood cells |
| 02/15/1993 | CA2076064A1 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products |
| 02/10/1993 | EP0527079A1 N-(isoquinolein-5-yl)-sulfonyl azacycloalkanes, their process of preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526877A2 Peptide aldehydes as antithrombotic agents |
| 02/10/1993 | EP0526544A1 Therapeutic uses of actin-binding compounds |
| 02/09/1993 | US5185442 New diazepines substituted in the 6-position, processes for their preparation and their use as pharmaceutical compositions |
| 02/09/1993 | US5185376 Administering compound with at least one N-oxo-N-nitrosoamine moiety; releases nitric oxide in sustained and controlled fashion in vivo |
| 02/09/1993 | US5185368 Complex with trivalent metal ions; medical diagnosis and therapy |
| 02/09/1993 | US5185361 Pharmaceutical compounds |
| 02/09/1993 | US5185352 Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/09/1993 | US5185160 Platelet membrane microvesicles |
| 02/09/1993 | CA2075673A1 (2-alkyl-3-pyridyl)methylpiperazine derivatives |
| 02/09/1993 | CA1313500C Pharmaceutical compositions for the treatment of occlusive vascular diseases |
| 02/07/1993 | CA2075154A1 Peptide aldehydes as antithrombotic agents |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002182A1 Yolk sac stem cells |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | CA2113555A1 Yolk sac stem cells |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/03/1993 | WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526342A1 Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0525960A1 Use of rapamycin for the treatment of adult T-cell leukemia/lymphoma |
| 02/03/1993 | EP0525629A2 5-membered heterocycles, process for their preparation and medicaments containing them |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0517740A4 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | CN1068574A Atp analogues |
| 02/02/1993 | CA2075010A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/01/1993 | CA2075017A1 (isoquinolein-5-yl) sulfonamides, process for their prepara tion and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074963A1 New n-[(isoquinolein-5-yl)sulfonyl] azacycloalcanes, preparation process and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/28/1993 | CA2074685A1 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 01/27/1993 | EP0524803A2 Thromboplastin extract, reagent, and preparation thereof |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0409940A4 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/26/1993 | US5182300 Furosemide salts |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/26/1993 | US5182113 Factor xa inibitor from leech and pharmaceutical compositions containing same |
| 01/21/1993 | WO1993001208A1 2-[3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use |
| 01/21/1993 | WO1993001207A1 Process for the purification of serum albumin |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | WO1993000914A1 Metabolizable plasma substitute |
| 01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | CA2113163A1 Metabolizable plasma substitute |
| 01/21/1993 | CA2112580A1 2-substituted 3-(4-amidinophenyl) propionic acid derivatives, the preparation and use thereof |
| 01/20/1993 | EP0524004A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives |
| 01/20/1993 | EP0523138A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes |
| 01/20/1993 | EP0523086A1 Pharmaceutical aqueous solution of 4- 2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
| 01/19/1993 | US5180723 Certain sulfonamide heterobicyclic platelet activating factor antagonists |
| 01/19/1993 | US5180668 Hirudin derivative |
| 01/19/1993 | CA1312861C Heparin derivatives and low molecular weight heparin derivatives |
| 01/19/1993 | CA1312860C Process for preparation of aloe products |
| 01/18/1993 | CA2074038A1 Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives |
| 01/14/1993 | DE4122999A1 Metabolisierbarer plasmaersatz Metabolizable plasma substitute |
| 01/13/1993 | EP0522080A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 01/13/1993 | EP0521986A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 01/13/1993 | EP0521873A1 Anticoagulant proteins |
| 01/12/1993 | US5179120 Porphycene compounds for photodynamic therapy |
| 01/12/1993 | US5179091 Chalcones |
| 01/12/1993 | US5179082 Method for blocking platelet adhesion to collagen |
| 01/12/1993 | US5178855 Treatment of luekocyte dysfunction with GM-CSF |
| 01/12/1993 | CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use |
| 01/12/1993 | CA1312609C Preparation of a piperidinylclopentylheptenoic acid derivative |
| 01/12/1993 | CA1312569C Csf and method for obtaining the same |
| 01/07/1993 | WO1993000433A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | WO1993000339A1 A novel salicylic acid-maltol conjugates |
| 01/07/1993 | WO1993000105A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | WO1993000097A1 Pharmaceutical preparations containing torasemid |
| 01/07/1993 | WO1993000095A2 Bicyclic fibrinogen antagonists |
| 01/07/1993 | WO1993000087A1 Porphycene compounds for photodynamic therapy |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1992014438A3 Prostacycline and carbacycline derivatives as agents for treating feverish complaints |
| 01/07/1993 | EP0521381A1 Use of 3-pyridazinone compounds to reduce blood platelet count |
| 01/07/1993 | DE4121947A1 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung 2- (3- (4-amidino-phenyl)) - propionic acid derivatives, their preparation and use |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | CA2111323A1 Porphycene compounds for photodynamic therapy |
| 01/06/1993 | CA2073117A1 Blood platelet-decreasing therapeutic drug |
| 01/02/1993 | WO1993000925A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2090463A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2072834A1 Ketone derivatives |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |